← Back to Clinical Trials
Recruiting NCT06278974

NCT06278974 Comparing Myopia Treatments in Youth: Defocus Spectacles, Glasses, and Ortho-K

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06278974
Status Recruiting
Phase
Sponsor He Eye Hospital
Condition Myopia
Study Type OBSERVATIONAL
Enrollment 90 participants
Start Date 2023-11-10
Primary Completion 2027-05-01

Eligibility & Interventions

Sex All sexes
Min Age 7 Years
Max Age 17 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 90 participants in total. It began in 2023-11-10 with a primary completion date of 2027-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The research project titled "A Comparative Study on the Clinical Efficacy, Quality of Life, and Cost of Use of Peripheral Defocus Spectacles, Frame Glasses, and Orthokeratology Lenses in Myopic Children and Adolescents" aims to evaluate different non-surgical myopia correction methods in children. It focuses on assessing the impact of peripheral defocus spectacles, frame glasses, and orthokeratology lenses on the quality of life, clinical effectiveness, and costs associated with each method. The study is a prospective cohort study involving 90 children aged 8-17 years with myopia ranging from -1.00D to -6.00D. It aims to compare the psychological, social, and educational aspects of these correction methods, alongside their costs and clinical outcomes over a period of one year.

Eligibility Criteria

Inclusion Criteria: * Children aged 7-17 years. * Myopia between -1.00D and -6.00D; astigmatism \<±1.5D; best corrected visual acuity ≥1.0. * First-time spectacle wearers who use a single correction method and meet the indications for it (any one of orthokeratology lenses, single-vision frame glasses, or myopia control frame glasses) * Willing to participate in the entire research process and complete all the examinations, questionnaires and cost records as required. * Be able to maintain contact throughout the research period, such as having a fixed address and contact information. Exclusion Criteria: * History of strabismus, amblyopia, refractive disparity or retinal diseases * Previous history of eye surgery * Severe psychological disorders or behavioral problems * History of allergy to contact lenses or contact lens care solutions

Contact & Investigator

Central Contact

lan Hu

✉ hulan@hsyk.com.cn

📞 +8615940406919

Principal Investigator

ruyi Li

PRINCIPAL INVESTIGATOR

He Eye Hospital

Frequently Asked Questions

Who can join the NCT06278974 clinical trial?

This trial is open to participants of all sexes, aged 7 Years or older, up to 17 Years, studying Myopia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06278974 currently recruiting?

Yes, NCT06278974 is actively recruiting participants. Contact the research team at hulan@hsyk.com.cn for enrollment information.

Where is the NCT06278974 trial being conducted?

This trial is being conducted at Shenyang, China.

Who is sponsoring the NCT06278974 clinical trial?

NCT06278974 is sponsored by He Eye Hospital. The principal investigator is ruyi Li at He Eye Hospital. The trial plans to enroll 90 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology